08-108: DENUFOSOL TETRASODIUM INHALATOIN SOLUTION IN MILD CF LUNG DISEASE

这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究旨在评价CF受试者接受60 mg剂量的地诺福索（INS 37217）吸入溶液与安慰剂每日3次给药，持续24周的安全性和疗效。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study aims to evaluate the safety and efficacy of a 60 mg dose of Denufosol (INS37217) Inhalation Solution compard to a placebo administered 3 times daily over 24 weeks in subjects with CF.